Benefit-Risk Appraisal of Medicines

Discover the essential guide to understanding the complexities of benefit-risk appraisal in the pharmaceutical industry with Benefit-Risk Appraisal of Medicines by Sam Salek. Published by John Wiley & Sons Inc in 2009, this comprehensive hardback spans 304 pages and delves into the critical criteria necessary for assessing benefits and risks associated with medications.

This book not only reviews the current practices of benefit-risk assessment employed by drug regulatory authorities and the pharmaceutical sector but also introduces a groundbreaking Multi-Criteria Decision Analysis (MCDA) model. Sam Salek discusses the development and evaluation of this innovative model, shedding light on its significant implications for drug evaluation practices.

Whether you are a healthcare professional, a policy maker, or a student in the field of pharmacology, this book is an invaluable resource for enhancing your understanding of risk assessment and decision-making in medicine.